```markdown
| Country | Comparator | Population details |
|---------|------------|--------------------|
| UK      | Sotorasib  | Previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer |
| UK      | Chemotherapy | KRAS G12C mutation-positive locally advanced or metastatic NSCLC |
```